0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Environmental Sources Human Health Effects Sign in to save

Microplastics as an emerging driver of osteoarthritis: a translational synthesis of environmental exposure, patho-mechanisms, and public health implications

Journal of Translational Medicine 2025 Score: 48 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Muhammad Adil Malik, Song Wu, Wenxiu Zhang, Junjie Huang, Xu Cao, Uroosa Ayub, Adnan Malik

Summary

A translational synthesis of clinical and experimental data examined the role of microplastic exposure in osteoarthritis (OA) development, finding evidence that MPs bioaccumulate in joint tissues and may promote inflammation and oxidative damage that disrupts cartilage homeostasis. The review identified MP exposure as a plausible but underexplored contributor to OA progression.

BACKGROUND: Osteoarthritis (OA), a leading global cause of disability, has been increasingly associated with environmental microplastic (MP) exposure. MPs bioaccumulate in human tissues via the food chain and may disrupt joint homeostasis through inflammatory and oxidative pathways. However, their role in OA pathogenesis remains underexplored in translational contexts. METHODS: We conducted a synthesis of environmental microplastic contamination data from global aquatic ecosystems, integrated with molecular pathway analyses and epidemiological evidence. Microplastic sampling and polymer identification were performed using GPS mapping, stereomicroscopy, and Fourier-transform infrared (FTIR) spectroscopy. Public health implications were assessed through cost-effectiveness analyses of MP mitigation strategies. RESULTS: High MP exposure regions demonstrated elevated OA prevalence, with MPs identified in cartilage and skeletal tissues. Mechanistically, MPs activated NLRP3 inflammasomes, induced reactive oxygen species (ROS), and disrupted osteoblast/osteoclast balance. Epidemiological data revealed that populations in coastal and industrial regions exhibited up to 1.85-fold increased OA risk. Cost-benefit modeling indicated that MP reduction strategies, such as seafood safety regulations and advanced water filtration, could yield annual healthcare savings exceeding $50 billion globally. CONCLUSIONS: Microplastics constitute an emerging and modifiable environmental risk factor for OA. Translational strategies targeting MP reduction may mitigate OA burden and offer substantial public health and economic benefits. This underscores the need for integrated environmental-health policies and further clinical investigation.

Sign in to start a discussion.

More Papers Like This

Article Tier 2

Environmental pollutants as emerging risk factors in osteoarthritis: Mechanistic and epidemiological evidence

This review synthesized mechanistic and epidemiological evidence linking environmental pollutants — including microplastics — to osteoarthritis pathogenesis. The authors found accumulating in vitro, animal, and human data suggesting that chemical exposures accelerate cartilage degradation and joint inflammation through multiple pathways.

Article Tier 2

Bridging relevance between microplastics, human health and bone metabolism: Emerging threats and research directions

Researchers reviewed how microplastics — tiny plastic fragments that accumulate in tissues throughout the body — may disrupt bone metabolism by triggering inflammation, oxidative stress, and hormonal interference, raising concern that widespread microplastic exposure could contribute to bone diseases like osteoporosis.

Article Tier 2

Microplastics aggravates rheumatoid arthritis by affecting the proliferation/migration/inflammation of fibroblast-like synovial cells by regulating mitochondrial homeostasis

Researchers investigated how microplastics affect the joint tissue cells involved in rheumatoid arthritis using lab and animal models. They found that microplastic exposure promoted the growth, spread, and inflammatory activity of these cells, while also worsening cartilage damage through disruption of mitochondrial function. The study suggests that microplastic exposure may aggravate inflammatory joint conditions by interfering with cellular energy processes.

Article Tier 2

Identification and analysis of microplastics in human lower limb joints

Researchers found microplastics in the joint tissue of all 45 patients undergoing hip or knee replacement surgery, identifying nine different types of plastic. Hip joints contained more microplastics than knee joints, and higher concentrations were linked to increased cellular stress responses. This is one of the first studies to confirm that microplastics accumulate in human joints, raising questions about their potential role in joint disease.

Article Tier 2

Microplastics in Musculoskeletal Disorders: An Emerging Threat

This review examines the emerging evidence that microplastics may affect the musculoskeletal system, including bones, cartilage, and muscles. Researchers found that microplastics can enter the body through ingestion, inhalation, and skin absorption, potentially triggering oxidative stress and inflammation in musculoskeletal tissues. The study suggests that more research is needed to understand the long-term impacts of microplastic exposure on bone and joint health.

Share this paper